De Novo MS/MS Sequencing of Native Human Antibodies.

De Novo MS/MS Sequencing of Native Human Antibodies.
复制标题

人类本地抗体的从头开始的MS/MS测序。

DOI:
10.1021/acs.jproteome.6b00608
复制
发表时间:
2017-01-06
影响因子:
4.4
通讯作者:
Bandeira N
Bandeira N
中科院分区:
生物学2区
文献类型:
--
作者:
Guthals A;Gan Y;Murray L;Chen Y;Stinson J;Nakamura G;Lill JR;Sandoval W;Bandeira N

文献摘要

参考文献

被引文献

相似文献

发现治疗性人类单克隆抗体 (mAb) 的一种直接途径是在暴露于感染性试剂或疾病病因后,从幸存者/血清阳性个体中分离外周 B 细胞,然后进行单细胞测序或杂交瘤生成。然而,外周 B 细胞并不总是容易获得,并且仅占所有身体组织中总 B 细胞群的一小部分。尽管已经证明串联质谱 (MS/MS) 技术可以询问体内对抗原的完整多克隆抗体 (pAb) 反应,但当前所有方法都根据来自同一患者 B 细胞基因测序的数据库来识别 MS/MS 谱图。在这项概念验证研究中,我们证明了一种新型 MS/MS 抗体发现方法的可行性,该方法仅需要血清抗体,而不需要对遗传物质进行测序。通过糖蛋白 B 抗原亲和力纯化来自 CMV 暴露个体的外周 pAb,并根据 MS/MS 数据进行从头测序。然后在哺乳动物细胞中制造纯 MS 衍生的 mAb,通过抗原结合 ELISA 验证效力。有趣的是,我们发现这些 mAb 占供体 IgG 总量的 1-2%,但在对同一患者的记忆 B 细胞进行平行测序时未检测到。
One direct route for the discovery of therapeutic human monoclonal antibodies (mAbs) involves the isolation of peripheral B cells from survivors/sero-positive individuals after exposure to an infectious reagent or disease etiology followed by single-cell sequencing or hybridoma generation. Peripheral B cells, however, are not always easy to obtain and only represent a small percentage of the total B cell population across all bodily tissues. Although it has been demonstrated that tandem mass spectrometry (MS/MS) techniques can interrogate the full polyclonal antibody (pAb) response to an antigen in vivo, all current approaches identify MS/MS spectra against databases derived from genetic sequencing of B cells from the same patient. In this proof-of-concept study, we demonstrate the feasibility of a novel MS/MS antibody discovery approach in which only serum antibodies are required, without the need for sequencing of genetic material. Peripheral pAbs from a CMV exposed individual were purified by glycoprotein B antigen-affinity and de novo sequenced from MS/MS data. Purely MS-derived mAbs were then manufactured in mammalian cells to validate potency via antigen-binding ELISA. Interestingly, we found that these mAbs accounted for 1–2% of total donor IgG but were not detected in parallel sequencing of memory B cells from the same patient.
DOI: 10.1038/nbt.2167
发表时间: 2012-05-01
影响因子: 46.9
作者:
Cheung, Wan Cheung;Beausoleil, Sean A.;Polakiewicz, Roberto D.
通讯作者: Polakiewicz, Roberto D.
DOI: 10.1002/pmic.201300366
发表时间: 2014-05-01
期刊: PROTEOMICS
影响因子: 3.4
作者:
Dekker, Lennard;Wu, Si;Pasa-Tolic, Ljiljana
通讯作者: Pasa-Tolic, Ljiljana
DOI: 10.1074/mcp.m111.015768
发表时间: 2012-10-01
影响因子: 7
作者:
Guthals, Adrian;Clauser, Karl R.;Bandeira, Nuno
通讯作者: Bandeira, Nuno
DOI: 10.1089/cmb.2009.0122
发表时间: 2009-08-01
影响因子: 1.7
作者:
Datta, Ritendra;Bern, Marshall
通讯作者: Bern, Marshall
DOI: 10.1074/mcp.m110.003731
发表时间: 2010-12-01
影响因子: 7
作者:
Kim, Sangtae;Mischerikow, Nikolai;Pevzner, Pavel A.
通讯作者: Pevzner, Pavel A.